At PCR, Drug-Eluting Stents Dominate the Discussion
Executive Summary
At this year's Paris Course on Revascularization, drug-eluting stents, not surprisingly, dominated the discussions. Clinical concerns about the new therapy have now given way to practical, economic concerns.